Breuer L, Huttner H B, Dörfler A, Schellinger P D, Köhrmann M
Neurologische Klinik, Universitätsklinikum Erlangen.
Fortschr Neurol Psychiatr. 2010 Feb;78(2):101-6. doi: 10.1055/s-0028-1109985. Epub 2010 Feb 9.
Up to 25 % of all acute ischemic strokes (AIS) occur during sleep with the patients or relatives becoming aware of their neurological deficits as they wake up. Because of the unclear time of stroke onset patients with stroke on awakening are usually not considered for acute therapies and excluded from most treatment trials. We give an overview of the published data regarding ischemic wake up strokes (WUS). In particular we focused on baseline characteristics, imaging methods and therapy strategies. Comparing WUS patients and patients with known stroke onset there were no major differences found regarding patient characteristics, etiology, clinical and radiological characteristics. Even though there is no existing gold standard multiparametric neuroimaging (CT; MRI) appears to be helpful for decision making whether to treat a WUS patient with thrombolysis or not. Especially multiparametric MRI which proved to be safe in patients within an extended time window might serve as an adequate diagnostic tool. The results of first pilot studies analyzing treatment of WUS demonstrate that a substantial number of these patients can be treated with IV thrombolysis (IVT) successfully. Large randomized, controlled, prospective clinical trials for patients with WUS are needed to test safety and efficacy of IVT and to evaluate the assumed benefit of multiparametric neuroimaging techniques in this patient group. The results of first pilot studies may be instrumental to help plan and design such trials.
高达25%的急性缺血性卒中(AIS)发生在睡眠期间,患者或其亲属在醒来时才意识到神经功能缺损。由于卒中发病时间不明,觉醒时发生卒中的患者通常不考虑接受急性治疗,并且被排除在大多数治疗试验之外。我们对已发表的关于缺血性觉醒卒中(WUS)的数据进行综述。我们特别关注基线特征、成像方法和治疗策略。比较WUS患者和已知卒中发病时间的患者,在患者特征、病因、临床和放射学特征方面未发现重大差异。尽管目前没有金标准,但多参数神经成像(CT;MRI)似乎有助于决定是否对WUS患者进行溶栓治疗。尤其是多参数MRI,在延长的时间窗内被证明对患者是安全的,可能是一种合适的诊断工具。分析WUS治疗的首批初步研究结果表明,相当数量的此类患者可以成功接受静脉溶栓(IVT)治疗。需要针对WUS患者开展大型随机、对照、前瞻性临床试验,以测试IVT的安全性和有效性,并评估多参数神经成像技术在该患者群体中的假定益处。首批初步研究结果可能有助于此类试验的规划和设计。